Page 89 - GPD-1-2

Gene & Protein in Disease Diagnosis and treatment of aldosterone-related diseases

https://doi.org/10.1016/s1262-3636(07)70122-2 Arterial wall inflammation and increased hematopoietic
activity in patients with primary aldosteronism. J Clin
5. Dooley R, Harvey BJ, Thomas W, 2012, Non-genomic actions
of aldosterone: from receptors and signals to membrane Endocrinol Metab, 105(5): e1967–e1980.
targets. Mol Cell Endocrinol, 350(2): 223–234. https://doi.org/10.1210/clinem/dgz306
https://doi.org/10.1016/j.mce.2011.07.019 17. Zhu Z, 2021, Causes and countermeasures of cardiovascular
events in chronic kidney disease. Chin J Integr Trad Western
6. Chen ZW, Tsai CH, Pan CT, et al., 2019, Endothelial
dysfunction in primary aldosteronism. Int J Mol Sci, 20(20): Nephrol, 22(10): 847-853.
5214. 18. Berney M, Vakilzadeh N, Maillard M, et al., 2021, Bariatric
https://doi.org/10.3390/ijms20205214 surgery induces a differential effect on plasma aldosterone
in comparison to dietary advice alone. Front Endocrinol
7. Yanan L, 2021, Value of parathyroid hormone level in (Lausanne), 12: 745045.
differential diagnosis of patients with primary aldosteronism
and nonfunctional adrenal tumors. J Chin Pla Postgrad Med https://doi.org/10.3389/fendo.2021.745045
Sch, 42(9): 913-917. 19. Do Carmo JM, da Silva AA, Hall V, 2021, Impact of
8. Tomilin VN, Pyrshev K, Khayyat NH, et al., 2021, With-no- mineralocorticoid receptor and angiotensin II Type 1
lysine kinase 1 (WNK ) augments TRPV function in the receptor antagonism on blood pressure regulation in obese
1
4
aldosterone-sensitive distal nephron. Cells, 10(6): 1482. Zucker rats: Role of sex differences. Am J Hypertens, 34(9):
999–1005.
https://doi.org/10.3390/cells10061482
https://doi.org/10.1093/ajh/hpaa170
9. Yanai K, Ishibashi K, Morishita Y, 2021, Systematic review
and meta-analysis of renin-angiotensin-aldosterone system 20. Wang P, Luo C, Zhu D, et al., 2021, Pericardial adipose
blocker effects on the development of cardiovascular disease tissue-derived leptin promotes myocardial apoptosis in
in patients with chronic kidney disease. Front Pharmacol, high-fat diet-induced obese rats through janus kinase 2/
+
+
12: 662544. reactive oxygen species/Na /K -ATPase signaling pathway.
J Am Heart Assoc, 10(18): e021369.
https://doi.org/10.3389/fphar.2021.662544
https://doi.org/10.1161/JAHA.121.021369
10. Ting C, 2022, Correlation among systolic blood pressure
load, renin-angiotensin-aldosterone system and cortisol in 21. Kalil GZ, Haynes WG, 2012, Sympathetic nervous system
patients with salt-sensitive hypertensive. Chin J Evid Bases in obesity-related hypertension: Mechanisms and clinical
Cardiovasc Med, 14(1): 84-86. implications. Hypertens Res, 35(1): 4-16.
11. Nianrong Z, 2021, Treatment of hypertension in diabetic https://doi.org/10.1038/hr.2011.173
patients. Chin J Clin, 49(12): 1399-1401. 22. Wang Y, Li CX, Lin YN, et al., 2021, The role of aldosterone
12. Colussi G, Catena C, Lapenna R, et al., 2007, Insulin in OSA and OSA-related hypertension. Front Endocrinol
resistance and hyperinsulinemia are related to plasma (Lausanne), 12: 801689.
aldosterone levels in hypertensive patients. Diabetes Care, https://doi.org/10.3389/fendo.2021.801689
30(9): 2349–2354.
23. Lin X, Ullah MH, Wu X, et al., 2021, Cerebro-cardiovascular
https://doi.org/10.2337/dc07-0525 risk, target organ damage, and treatment outcomes in
13. Bakris GL, Agarwal R, Anker SD, et al., 2019, Design and primary aldosteronism. Front Cardiovasc Med, 8: 798364.
baseline characteristics of the finerenone in reducing kidney https://doi.org/10.3389/fcvm.2021.798364
failure and disease progression in diabetic kidney disease
trial. Am J Nephrol, 50(5): 333–344. 24. Van der Heijden C, Horst RT, van den Munckhof IC, et
al., 2020, Vasculometabolic and inflammatory effects of
https://doi.org/10.1159/000503713 aldosterone in obesity. J Clin Endocrinol Metab, 105(8):
14. Briet M, Schiffrin EL, 2010, Aldosterone: effects on the 2719–2731.
kidney and cardiovascular system. Nat Rev Nephrol, 6(5): https://doi.org/10.1210/clinem/dgaa356
261–273.
25. Morimoto R, Omata K, Ito S, et al., 2018, Progress in the
https://doi.org/10.1038/nrneph.2010.30
management of primary aldosteronism. Am J Hypertens,
15. Tse LS, Liao PL, Tsai CH, et al., 2019, Glycemia lowering 31(5): 522–531.
effect of an aqueous extract of Hedychium coronarium leaves https://doi.org/10.1093/ajh/hpy018
in diabetic rodent models. Nutrients, 11(3): 629.
26. Shidlovskyi VO, Shidlovskyi OV, Tovkai OA, et al., 2019,
https://doi.org/10.3390/nu11030629
Topical diagnosis and determination of the primary
16. Van der Heijden C, Smeets EM, Aarntzen EH, et al., 2020, hyperaldosteronism variant. J Med Life, 12(4): 322–328.

Volume 1 Issue 2 (2022) 7 https://doi.org/10.36922/gpd.v1i2.136